Abstract
Background
Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) or autoimmune polyglandular syndrome type 1 (APS-1) is a rare autosomal recessive genetic disease due to mutations in the AIRE (AutoImmune REgulator) gene. The clinical diagnosis is classically based on the presence of at least two of the three main components: chronic mucocutaneous candidiasis, hypoparathyroidism and primary adrenal insufficiency. Patients often suffer from other endocrine or non-endocrine autoimmune conditions throughout life. APECED etiopathogenesis is mediated by T lymphocytes. Autoantibodies against proteins of the affected organs are found in the serum of APECED patients as well as neutralizing antibodies against cytokines. We report here the clinical and genetic characteristics of 45 Indian APECED patients in comparison to Finnish, Sardinian, Turkish and North/South American cohorts from their published results. We also report a new case of APECED of Indian origin, a 2-year old child suffering from chronic mucocutaneous candidiasis since the age of 8 months, with confirmatory AIRE homozygous mutation c.274C > T (p.R92W).
Conclusion
With the inherent limitations of a retrospective study, analysis of Indian APECED patients suggested that compared to classic criteria, application of Ferre/Lionakis criteria validated in North/South American patients could help in earlier diagnosis in 3 of 8 (37.5%) patients for whom adequate information for evaluation was available.
Similar content being viewed by others
References
Betterle C, Sabbadin C, Scaroni C, Presotto F (2019) Autoimmune Polyendocrine Syndromes (APS) or Multiple Autoimmune Syndromes (MAS). In: Colao A, Jaffrain-Rea ML, Beckers A (eds) Polyendocrine Disorders and Endocrine Neoplastic Syndromes, Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-319-73082-0_1-1
Fierabracci A (2011) Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity. Autoimmun Rev 10:137–143. https://doi.org/10.1016/j.autrev.2010.08.019
Laakso SM, Kekäläinen E, Rossi LH, Laurinolli TT, Mannerström H, Heikkilä N, Lehtoviita A, Perheentupa J, Jarva H, Arstila TP (2011) IL-7 dysregulation and loss of CD8+ T cell homeostasis in the monogenic human disease autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Immunol 187:2023–2030. https://doi.org/10.4049/jimmunol.1100212
Perniola R, Lobreglio G, Rosatelli MC, Pitotti E, Accogli E, De Rinaldis C (2005) Immunophenotypic characterisation of peripheral blood lymphocytes in autoimmune polyglandular syndrome type 1: clinical study and review of the literature. J Pediatr Endocrinol Metab 18:155–164. https://doi.org/10.1515/jpem.2005.18.2.155
Wolff ASB, Oftedal BE, Kisand K, Ersvaer E, Lima K, Husebye ES (2010) Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. Scand J Immunol 71:459–467. https://doi.org/10.1111/j.1365-3083.2010.02397.x
Ryan KR, Lawson CA, Lorenzi AR, Arkwright PD, Isaacs JD, Lilic D (2005) CD4+CD25+ T-regulatory cells are decreased in patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J Allergy Clin Immunol 116:1158–1159. https://doi.org/10.1016/j.jaci.2005.08.036
Kekäläinen E, Tuovinen H, Joensuu J, Gylling M, Franssila R, Pöntynen N, Talvensaari K, Perheentupa J, Miettinen A, Arstila TP (2007) A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Immunol 178:1208–1215. https://doi.org/10.4049/jimmunol.178.2.1208
Perri V, Gianchecchi E, Scarpa R, Valenzise M, Rosado MM, Giorda E, Crinò A, Cappa M, Barollo S, Garelli S, Betterle C, Fierabracci A (2017) Altered B cell homeostasis and Toll-like receptor 9-driven response in patients affected by autoimmune polyglandular syndrome Type 1: altered B cell phenotype and dysregulation of the B cell function in APECED patients. Immunobiology 222:372–373. https://doi.org/10.1016/j.imbio.2016.09.001
Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, Krohn KJ (1994) Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison’s disease. J Clin Endocrinol Metab 78:323–328. https://doi.org/10.1210/jcem.78.2.8106620
Fierabracci A (2009) Unravelling autoimmune pathogenesis by screening random peptide libraries with human sera. Immunol Lett 124:35–43. https://doi.org/10.1016/j.imlet.2009.04.001
Comerford R, Kelly J, Feighery C, Byrne G (2015) IgG anti-tTG responses in different autoimmune conditions differ in their epitope targets and subclass usage. Mol Immunol 67:369–376. https://doi.org/10.1016/j.molimm.2015.06.026
Scarpa R, Alaggio R, Norberto L, Furmaniak J, Chen S, Smith BR, Masiero S, Morlin L, Plebani M, De Luca F, Salerno MC, Giordano R, Radetti G, Ghizzoni L, Tonini G, Farinati F, Betterle C (2013) Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 98:704–712. https://doi.org/10.1210/jc.2012-2734
Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O (2008) Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 358:1018–1028. https://doi.org/10.1056/NEJMoa0706487
Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R, Pura M, Bøe Wolff AS, Husebye ES, Lilic D, Ryan KR, Gennery AR, Cant AJ, Abinun M, Spickett GP, Arkwright PD, Denning D, Costigan C, Dominguez M, McConnell V, Willcox N, Meager A (2008) Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 93:4389–4397. https://doi.org/10.1210/jc.2008-0935
Puel A, Döffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, Cobat A, Ouachée-Chardin M, Toulon A, Bustamante J, Al-Muhsen S, Al-Owain M, Arkwright PD, Costigan C, McConnell V, Cant AJ, Abinun M, Polak M, Bougnères PF, Kumararatne D, Marodi L, Nahum A, Roifman C, Blanche S, Fischer A, Bodemer C, Abel L, Lilic D, Casanova JL (2010) Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207:291–297. https://doi.org/10.1084/jem.20091983
Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327–364. https://doi.org/10.1210/edrv.23.3.0466
Perheentupa J (2006) Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 91:2843–2850. https://doi.org/10.1210/jc.2005-2611
Guo CJ, Leung PSC, Zhang W, Ma X, Gershwin ME (2018) The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1). Autoimmun Rev 17:78–85. https://doi.org/10.1016/j.autrev.2017.11.012
Husebye ES, Anderson MS, Kämpe O (2018) Autoimmune polyendocrine syndromes. N Engl J Med 378:1132–1141. https://doi.org/10.1056/NEJMra1713301
Betterle C, Salvà M, Sabbadin C, Garelli S (2016) La sindrome poliendocrina autoimmune di Tipo 1 in Italia. L’ Endocrinologo 17:10–20. https://doi.org/10.1007/s40619-016-0169-y
Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, Husebye ES, Furcas M, Rosatelli MC, Cao A, Congia M (2012) Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab 97:1114–1124. https://doi.org/10.1210/jc.2011-2461
Ferre EM, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, Rosen LB, Break TJ, Gu W, Hunsberger S, Browne SK, Hsu AP, Rampertaap S, Swamydas M, Collar AL, Kong HH, Lee CR, Chascsa D, Simcox T, Pham A, Bondici A, Natarajan M, Monsale J, Kleiner DE, Quezado M, Alevizos I, Moutsopoulos NM, Yockey L, Frein C, Soldatos A, Calvo KR, Adjemian J, Similuk MN, Lang DM, Stone KD, Uzel G, Kopp JB, Bishop RJ, Holland SM, Olivier KN, Fleisher TA, Heller T, Winer KK, Lionakis MS (2016) Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight 1:e88782. https://doi.org/10.1172/jci.insight.88782
Fierabracci A, Pellegrino M, Frasca F, Kilic SS, Betterle C (2018) APECED in Turkey: a case report and insights on genetic and phenotypic variability. Clin Immunol 194:60–66. https://doi.org/10.1016/j.clim.2018.06.012
Husebye ES, Perheentupa J, Rautemaa R, Kämpe O (2009) Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med 265:514–529. https://doi.org/10.1111/j.1365-2796.2009.02090.x
Weiler FG, Dias-da-Silva MR, Lazaretti-Castro M (2012) Autoimmune polyendocrine syndrome type 1: case report and review of literature. Arq Bras Endocrinol Metabol 56:54–66. https://doi.org/10.1590/s0004-27302012000100009
Fierabracci A (2016) Type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED): a "rare" manifestation in a "rare" disease. Int J Mol Sci 17:E1106. https://doi.org/10.3390/ijms17071106
Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829–1836. https://doi.org/10.1056/NEJM199006283222601
Perheentupa J, Miettinen A (1999) Autoimmune polyendocrine syndrome type I (APECED). In: Eisenbarth GS (ed) Endocrine and organ specific autoimmunity. RG Landes Company, Austin, pp 19–40
Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A (1996) Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 81:1488–1494. https://doi.org/10.1210/jcem.81.4.8636356
Cihakova D, Trebusak K, Heino M, Fadeyev V, Tiulpakov A, Battelino T, Tar A, Halász Z, Blümel P, Tawfik S, Krohn K, Lebl J, Peterson P (2001) Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED. Hum Mutat 18:225–232. https://doi.org/10.1002/humu.1178
Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD (2006) Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Br J Dermatol 154:1088–1093. https://doi.org/10.1111/j.1365-2133.2006.07166.x
Faiyaz-Ul-Haque M, Bin-Abbas B, Al-Abdullatif A, Abdullah Abalkhail H, Toulimat M, Al-Gazlan S, Almutawa AM, Al-Sagheir A, Peltekova I, Al-Dayel F, Zaidi SH (2009) Novel and recurrent mutations in the AIRE gene of autoimmune polyendocrinopathy syndrome type 1 (APS1) patients. Clin Genet 76:431–440. https://doi.org/10.1111/j.1399-0004.2009.01278.x
Ekwall O, Hedstrand H, Grimelius L, Haavik J, Perheentupa J, Gustafsson J, Husebye E, Kämpe O, Rorsman F (1998) Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 352:279–283
Sköldberg F, Portela-Gomes GM, Grimelius L, Nilsson G, Perheentupa J, Betterle C, Husebye ES, Gustafsson J, Rönnblom A, Rorsman F, Kämpe O (2003) Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells. J Clin Endocrinol Metab 88:1445–1452
Mahto B, Kundu P, Ghosh A, Dhar S (2018) A novel case of chronic mucocutaneous candidiasis: overlap between autoimmune polyendocrinopathy, candidiasis, ectodermal dystrophy syndrome and hyper IgE syndrome. Indian J Paediatr Dermatol 19:241–244. https://doi.org/10.4103/ijpd.ijpd_20_17
Cervato S, Mariniello B, Lazzarotto F, Morlin L, Zanchetta R, Radetti G, De Luca F, Valenzise M, Giordano R, Rizzo D, Giordano C, Betterle C (2009) Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives. Clin Endocrinol 70:421–428. https://doi.org/10.1111/j.1365-2265.2008.03318.x
Meloni A, Perniola R, Faà V, Corvaglia E, Cao A, Rosatelli MC (2002) Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from southern Italy. J Clin Endocrinol Metab 87:841–846. https://doi.org/10.1210/jcem.87.2.8209
Valenzise M, Fierabracci A, Cappa M, Porcelli P, Barcellona R, De Luca F, Barollo S, Garelli S, Betterle C (2014) Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: report of seven additional sicilian patients and overview of theoverall series from Sicily. Horm Res Paediatr 82:127–132. https://doi.org/10.1159/000363537
Palma A, Crinó A, Palombi M, Cappa M, Fierabracci A (2013) Peculiar genotypes of the autoimmune regulator gene in Italian patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Clin Lab 59:675–680
Capalbo D, Mazza C, Giordano R, Improda N, Arvat E, Cervato S, Morlin L, Pignata C, Betterle C, Salerno M (2012) Molecular background and genotype-phenotype correlation in autoimmune-polyendocrinopathy-candidiasis-ectodermal-distrophy patients from Campania and in their relatives. J Endocrinol Invest 32:169–173. https://doi.org/10.3275/7677
Cetani F, Barbesino G, Borsari S, Pardi E, Cianferotti L, Pinchera A, Marcocci C (2001) A novel mutation of the autoimmune regulator gene in an italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 86:4747–4752. https://doi.org/10.1210/jcem.86.10.7884
Oftedal BE, Hellesen A, Erichsen MM, Bratland E, Vardi A, Perheentupa J, Kemp EH, Fiskerstrand T, Viken MK, Weetman AP, Fleishman SJ, Banka S, Newman WG, Sewell WA, Sozaeva LS, Zayats T, Haugarvoll K, Orlova EM, Haavik J, Johansson S, Knappskog PM, Løvås K, Wolff AS, Abramson J, Husebye ES (2015) Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity 42:1185–1196. https://doi.org/10.1016/j.immuni.2015.04.021
Magitta NF, Pura M, Bøe Wolff AS, Vanuga P, Meager A, Knappskog MP, Husebye ES (2008) Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison’s disease. Eur J Endocrinol 158:705–709. https://doi.org/10.1530/EJE-07-0843
Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kämpe O, Rorsman F, Peltonen L, Ulmanen I, Partanen J (2002) AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab 87:2568–2574. https://doi.org/10.1210/jcem.87.6.8564
Virili C, Fallahi P, Antonelli A, Benvenga S, Centanni M (2018) Gut microbiota and Hashimoto's thyroiditis. Rev Endocr Metab Disord 19:293–300. https://doi.org/10.1007/s11154-018-9467-y
Thomas RM, Jobin C (2020) Microbiota in pancreatic health and disease: the next frontier in microbiome research. Nat Rev Gastroenterol Hepatol 17:53–64. https://doi.org/10.1038/s41575-019-0242-7
Hansen CH, Yurkovetskiy LA, Chervonsky AV (2016) Cutting edge: commensal microbiota has disparate effects on manifestations of polyglandular autoimmune inflammation. J Immunol 197:701–705. https://doi.org/10.4049/jimmunol.1502465
Gianchecchi E, Fierabracci A (2019) Recent advances on microbiota involvement in the pathogenesis of autoimmunity. Int J Mol Sci 20:283. https://doi.org/10.3390/ijms20020283
Poojary SA, Lodha N, Gupta N (2015) Psoriasis in autoimmune polyendocrine syndrome type I: a possible complication or a non-endocrine minor component? Indian J Dermatol Venereol Leprol 81:166–169. https://doi.org/10.4103/0378-6323.152285
Pal N, Raj HJ, Das A, Maiti PK (2015) A rare case of autoimmuno polyglandular syndrome type I in two siblings: first case from Eastern India. Int J Curr Microbiol Appl Sci 4:50–54
Khan GQ, Hassan G, Qureshi W, Kak M, Kadri M, Akhter D, Bakshi J (2005) Polyglandular Autoimmune Syndrome Type-I. JIACM 6:155–157
Ponranjini VC, Jayachandran S, Kayal L, Bakyalakshmi K (2012) Autoimmune polyglandular syndrome type 1. J Clin Imaging Sci 2:1–4. https://doi.org/10.4103/2156-7514.103018
Wani AI, Farooqui KJ, Bashir MI, Mir SA, Lone AA, Masoodi SR (2013) Autoimmune polyglandular syndrome type 1 with reversible dilated cardiomyopathy: complete recovery after correction of hypocalcemia and hypocortisolemia. J Pediatr Endocrinol Metab 26:373–376. https://doi.org/10.1515/jpem-2012-0201
Bhansali A, Kotwal N, Suresh V, Murlidharan R, Chattopadhyay A, Mathur K (2003) Polyglandular autoimmune syndrome type 1 without chronic mucocutaneous candidiasis in a 16 year-old male. J Pediatr Endocrinol Metab 16:103–106. https://doi.org/10.1515/jpem.2003.16.1.103
Zaidi G, Sahu RP, Zhang L, George G, Bhavani N, Shah N, Bhatia V, Bhansali A, Jevalikar G, Jayakumar RV, Eisenbarth GS, Bhatia E (2009) Two novel AIRE mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) among Indians. Clin Genet 76:441–448. https://doi.org/10.1111/j.1399-0004.2009.01280.x
Zaidi G, Bhatia V, Sahoo SK, Sarangi AN, Bharti N, Zhang L, Yu L, Eriksson D, Bensing S, Kämpe O, Bharani N, Yachha SK, Bhansali A, Sachan A, Jain V, Shah N, Aggarwal R, Aggarwal A, Srinivasan M, Agarwal S, Bhatia E (2017) Autoimmune polyendocrine syndrome type 1 in an Indian cohort: a longitudinal study. Endocr Connect 6:289–296. https://doi.org/10.1530/EC-17-0022
Sivabalan S, Mahadevan S, Srinath MV (2014) Recurrent oral thrush. Indian J Pediatr 81:394–396. https://doi.org/10.1007/s12098-013-1201-x
Sardesai VR, Agarwal TD, Salampuria SN (2013) Alopecia universalis in polyglandular autoimmune syndrome type I. Int J Trichology 5:164–165. https://doi.org/10.4103/0974-7753.125624
Laway BA, Ganie MA, War FA, Mir SA, Roshan R, Zargar AH (2010) Varying presentation of type 1 polyglandular failure in India. J Pediatr Endocrinol Metab 23:271–276. https://doi.org/10.1515/jpem.2010.23.3.271
Sahoo SK, Zaidi G, Srivastava R, Sarangi AN, Bharti N, Eriksson D, Bensing S, Kämpe O, Aggarwal A, Aggarwal R, Bhatia E (2016) Identification of autoimmune polyendocrine syndrome type 1 in patients with isolated hypoparathyroidism. Clin Endocrinol 85:544–550. https://doi.org/10.1111/cen.13111
Makharia G, Tandon N, Stephen N, Gupta S, Tandon R (2007) Primary intestinal lymphangiectasia as a component of autoimmune polyglandular syndrome type I: a report of 2 cases. Indian J Gastroenterol 26:293–295
Patel ML, Sachan R, Patil MR, Mishra A (2012) Autoimmune polyglandular syndrome type-1. J Assoc Physicians India 60:61
Joshi RR, Rao S, Prabhu SS (2006) Polyglandular autoimmune syndrome type 1. Indian Pediatr 43:1085–1087
Trivedi SV, Joshi C, Amichandwala K, Porwal V, Arora P (2004) Polyglandular autoimmune syndrome type-1. Assoc Physicians India 52:681–682
Funding
This research was funded by the Italian Ministry of Health Ricerca Corrente RC2019.1.6.
Author information
Authors and Affiliations
Contributions
AF wrote the manuscript, performed literature search and supervised the experimental work. AA and FT performed literature search and conduct analysis of the AIRE gene. NG, AP and MM performed autoantibodies assays. MK, CKG, RG, VSN conducted the clinical investigation on the patient and his family. CB critically revised the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Research involving human participants and/or animals
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent provided by the Indian parents at the Dept of Immunology, JIPMER, Pondicherry, India.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fierabracci, A., Arena, A., Toto, F. et al. Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients. J Endocrinol Invest 44, 661–677 (2021). https://doi.org/10.1007/s40618-020-01376-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-020-01376-5